NCT05003388RecruitingPhase 1
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for MS
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells for the treatment of multiple sclerosis
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 6 Aug 2021
- Start date
- 26 Jun 2021
- Primary completion date
- Oct 2028
- Lead sponsor
- The Foundation for Orthopaedics and Regenerative Medicine
- Diseases
- Multiple sclerosis
- NCT number
- NCT05003388
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 15
- From 26 Jun 2021 to the primary completion date, Oct 2028
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Continued drug abuse
- Previous organ transplant
Other illness
- Active infection
- Active cancer
- Chronic multisystem organ failure
- Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
- Hypersensitivity to sulfur
Lab values
- Clinically significant abnormalities on pre-treatment laboratory evaluation
Other
- Pregnancy
- Pre-menopausal women not using contraception
Who the study is looking for
- Diagnosis of Multiple Sclerosis
- Understanding and willingness to sign a written informed consent document
Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Prodromos Stem Cell Institute Coordinator of this site? Confirm its status | Athens | Greece | Recruiting |
| Prodromos Stem Cell Institute Coordinator of this site? Confirm its status | Naples | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.